Finance

Beta
Lists
082800:KOSDAQ
Vivozon Pharmaceutical Co Ltd
₩2,285.00
-4.99%
(-120.00) 1D
May 29, 3:30:10 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 082800...
Open
₩2,410
High
₩2,450
Low
₩2,245
Mkt. cap
138.74B
Avg. vol.
530.48K
Volume
506.63K
52-wk high
₩8,275
52-wk low
₩2,245
EPS
-₩547
Shares outstanding
60.72M
No. of employees
303
Open
₩2,410
High
₩2,450
Low
₩2,245
Mkt. cap
138.74B
Avg. vol.
530.48K
Volume
506.63K
52-wk high
₩8,275
52-wk low
₩2,245
EPS
-₩547
Shares outstanding
60.72M
No. of employees
303
News stories
From sources across the web
About Vivozon Pharmaceutical Co Ltd
CEO-
Employees303
Founded2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
18.59B
17.80B
6.76B
16.20B
Cost of goods sold
8.98B
8.82B
7.80B
9.56B
Cost of revenue
8.98B
8.82B
7.80B
9.56B
Research and development expenses
1.20B
839.43M
534.26M
755.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.82B
10.51B
8.21B
8.82B
Operating expense
12.10B
11.71B
9.17B
10.37B
Total operating expenses
21.09B
20.53B
16.96B
19.93B
Operating income
-2.50B
-2.73B
-10.20B
-3.73B
Other non operating income
46.21M
-22.74M
-3.76M
276.32M
EBT including unusual items
-3.75B
-4.22B
-11.58B
-12.73B
EBT excluding unusual items
-3.75B
-4.22B
-11.58B
-6.14B
Income tax expense
-
-
-
48.61M
Effective tax rate
-
-
-
-0.38%
Other operating expenses
-
-
-
-
Net income
-3.77B
-4.22B
-11.64B
-12.79B
Net profit margin
-20.30%
-23.73%
-172.29%
-78.93%
Earnings per share
-
-
-
-
Interest and investment income
39.98M
38.84M
18.83M
99.82M
Interest expense
-509.80M
-511.31M
-551.99M
-629.92M
Net interest expenses
-469.82M
-472.47M
-533.16M
-530.10M
Depreciation and amortization charges
205.56M
196.02M
202.63M
196.55M
EBITDA
-1.42B
-1.70B
-9.17B
-2.44B
Gain or loss from assets sale
-
-1.92M
-392.79K
91.78M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more